Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Researcher index
Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10Safety, feasibility, and preliminary clinical outcomes of psilocybin-assisted therapy for veterans with severe, treatment-resistant PTSD: an open-label pilot clinical trialCommunications Medicine · 2026-07-30A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-07-23Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.Psychiatry research · 2026-05-01Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety RecommendationsmedRxiv · 2026-04-30Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use DisorderAmerican Journal of Neuroradiology · 2026-04-24A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)ClinicalTrials.gov · 2026-04-22Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31Low, non-psychedelic doses of psilocybin as a novel treatment for MASLD, obesity and type 2 diabetes via 5-HT2B receptor-dependent mechanismsRepository for Publications and Research Data (ETH Zurich) · 2026-01-20The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety- and Depressive-Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors.Journal of neuroscience research · 2026-01-01The Effect of on Spatial Memory and BDNF Expression in Male Rats Exposed to Chronic Unpredictable Mild Stress.Journal of psychoactive drugs · 2026-01-01Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions.Psychedelic medicine (New Rochelle, N.Y.) · 2025-12-01Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applicationsCaderno Pedagógico · 2025-10-31Five-year outcomes of psilocybin-assisted therapy for Major Depressive DisorderJournal of Psychedelic Studies · 2025-09-04Serotonin and psilocybin activate 5-HT receptors to suppress cortical signaling through the claustrum.Nature communications · 2025-08-19Substance Abuse and Cognitive Decline: The Critical Role of Tau Protein as a Potential Biomarker.International journal of molecular sciences · 2025-08-07Psychedelic and Medicinal Mushrooms: Potent Source of Active Metabolites and MedicinesCurrent Bioactive Compounds · 2025-07-02ALSUntangled #77: Psilocybin.Amyotrophic lateral sclerosis & frontotemporal degeneration · 2025-05-01IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT receptors in mouse models of chronic pain.Pharmacological research · 2025-05-01Patterns of Internalizing Problems, Substance Use and Cognitive Flexibility Before and After Naturalistic Psilocybin Use: A Repeated Measures Latent Profile AnalysisInternational Journal of Mental Health and Addiction · 2025-04-24Psilocybe cubensis y Panaeolus cyanescens (Basidiomycota, Agaricales), dos especies de hongos alucinógenos en el NE de ArgentinaBoletín de la Sociedad Argentina de Botánica · 2025-04-01Psilocin, A Psychedelic Drug, Exerts Anticonvulsant Effects Against PTZ- and MES-Induced Seizures in Mice via 5-HT1A and CB1 Receptors: Involvement of Nitrergic, Opioidergic, and Kynurenine PathwaysPharmacology Research & Perspectives · 2025-04-01Latent Class Analysis of Changes in Substance Use and Depressive Symptoms following Naturalistic Psilocybin Use: Results from a Prospective Longitudinal SurveyDrug and Alcohol Dependence · 2025-02-01Examining differences in the effects and contexts of naturalistic psilocybin use for White participants vs. Participants of Color: A longitudinal online survey study.Journal of affective disorders · 2025-02-01Research and Implementation of Psychedelic-Assisted Therapy in the Veterans Health Administration.The American journal of psychiatry · 2025-01-01Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review.Clinical neuropharmacology · 2025-01-01Distinct classes of antidepressants commonly act to shape pallidal structure and function in micebioRxiv · 2024-09-24The Epidemiology of Psychedelic Use Among United States Military VeteransJournal of Psychoactive Drugs · 2024-09-12Acute Psychedelic Effects and Clinical Outcomes are Associated With Therapeutic Alliance Among Participants Receiving Psilocybin TherapyDrug and Alcohol Dependence · 2024-07-01Associations Between Harm Reduction Strategy Use and Acute Psychedelic Effects in Spanish Speakers who Used LSD or PsilocybinDrug and Alcohol Dependence · 2024-07-01Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogensPsychiatry and Clinical Neurosciences Reports · 2024-05-16Ethopharmacological evaluation of antidepressant-like effect of serotonergic psychedelics in C57BL/6J male mice.Naunyn-Schmiedeberg's archives of pharmacology · 2024-05-01Therapeutics Uses of Psychedelics in patients with psychiatric disorders A Systematic ReviewJournal For International Medical Graduates · 2024-04-18Pharmacology of Classical Psychedelic in Mouse Models of Chronic PainJournal of Pain · 2024-03-31Psychedelic Renaissance: Evidence and CulturePsychiatric News · 2024-03-21The therapeutic alliance between study participants and intervention facilitators is associated with acute effects and clinical outcomes in a psilocybin-assisted therapy trial for major depressive disorder.PloS one · 2024-01-01Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.Journal of psychoactive drugs · 2024-01-01Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers.Psychedelic medicine (New Rochelle, N.Y.) · 2023-12-01Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Shame, guilt and psychedelic experience: Results from a prospective, longitudinal survey of real-world psilocybin usePsyArXiv · 2023-10-14Psilocybin therapy: A novel approach to treating depressionInternational Journal of Surgery Global Health · 2023-06-02Naturalistic psilocybin use is associated with persisting improvements in mental health and wellbeing: results from a prospective, longitudinal survey.Frontiers in psychiatry · 2023-01-01Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discriminationForensic Chemistry · 2022-04-08Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.Journal of psychopharmacology (Oxford, England) · 2022-02-01Psilocybin therapy increases cognitive and neural flexibility in patients with major depressive disorder.Translational psychiatry · 2021-11-08Use of alternative therapy with Psilocybin in oncologic patients with depression and/or anxiety disorders - integrative reviewResearch Society and Development · 2021-08-19Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.JAMA psychiatry · 2021-05-01People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences.Drugs (Abingdon, England) · 2021-01-01Emotions and brain function are altered up to one month after a single high dose of psilocybin.Scientific reports · 2020-02-10Psychoactive plant- and mushroom-associated alkaloids from two behavior modifying cicada pathogensbioRxiv · 2018-07-24Cancer at the Dinner Table: Experiences of Psilocybin-Assisted Psychotherapy for the Treatment of Cancer-Related Psychological DistressWestern CEDAR (Western Washington University) · 2018-01-01Naltrexone but Not Ketanserin Antagonizes the Subjective, Cardiovascular, and Neuroendocrine Effects of Salvinorin-A in Humans.The international journal of neuropsychopharmacology · 2016-07-01[CLINICAL AND PSYCHOPATHOLOGICAL STUDY OF PSILOCYBIN].Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali · 1964-03-31[Initial results of the action of psilocybin in a group of psychiatric patients].Rivista di neurologia · 1962-01-01